Rapid Analysis of Immuno-suppressants Using Triple Quadrupole LC-MS/MS

Importance of the Topic

Therapeutic drug monitoring of immunosuppressants is critical in transplant medicine to ensure patient safety and graft survival. Fast and sensitive analytical methods enable prompt dose adjustments, reduce toxicity risks, and support high-throughput clinical workflows.

Objectives and Study Overview

The study aimed to develop and validate an ultra-fast LC-MS/MS method for simultaneous quantification of four key immunosuppressants (tacrolimus, everolimus, rapamycin, cyclosporin A) alongside two internal standards (ascomycin, cyclosporin D) within a single 1.8-minute run.

Methodology and Instrumentation

Chromatography was performed on a Shimadzu Nexera X2 UHPLC system using a YMC-Triart C18 column (30 mm × 2 mm I.D., 1.9 µm). A binary gradient of 1 mmol/L ammonium acetate in water (mobile phase A) and methanol (mobile phase B) ramped from 60 % to 95 % B in under a minute. Electrospray ionization in negative mode on the Shimadzu LCMS-8050 triple quadrupole provided targeted multiple reaction monitoring (MRM). Key MS parameters included a drying gas flow of 5 L/min, nebulizer gas at 3 L/min, interface temperature at 400 ℃, and collision-induced dissociation to product ions ranging from m/z 321.20 to 1102.60.

Main Results and Discussion

The method achieved limits of quantitation down to 1 ng/mL for all analytes with only 1.5 µL injection volumes. Calibration was linear across therapeutic ranges (tacrolimus 0.5–500 ng/mL; everolimus 0.2–200 ng/mL; rapamycin 0.5–500 ng/mL; cyclosporin A 0.2–1000 ng/mL). Intra-run precision (%RSD) at the lower limit of quantitation ranged from 7.55 % to 19.2 %, and accuracy remained within 85–115 %. Chromatographic separation maintained peak resolution despite the sub-2-minute cycle, demonstrating robustness for routine analysis.

Benefits and Practical Applications

• High throughput: sub-2-minute analysis enables processing of dozens of samples per hour.
• Clinical relevance: meets sensitivity and precision requirements for therapeutic drug monitoring.
• Resource efficiency: low solvent consumption and minimal sample volume.

Future Trends and Potential Applications

Further integration with automated sample preparation could streamline workflows in clinical laboratories. Expanding this approach to additional narrow-therapeutic-index drugs and incorporating high-resolution MS would enhance multiplexing capabilities and confirmatory power.

Conclusion

The developed triple quadrupole LC-MS/MS method delivers rapid, sensitive, and reliable quantification of critical immunosuppressants, supporting high-throughput clinical monitoring while maintaining regulatory standards for precision and accuracy.

References

• Shimadzu Corporation. Rapid Analysis of Immuno-suppressants Using Triple Quadrupole LC-MS/MS. First Edition, June 2014.
• Department of Pharmacy, Kyoto University Hospital. Acknowledgements.